Skip to search formSkip to main contentSkip to account menu

P-1496

Known as: P 1496, P1496 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Zeranol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Work in progress: quality of life (QoL) and neurological disease - trajectories of outcome in neurological conditions (TONiC): a study protocol
UNC13A influences survival in an Italian population-based series A. Calvo1, G. Restagno2, M. Brunetti2, I. Ossola2, E. Majounie3… 
1983
1983
Immunosuppression Following Exposure to Exogenous Estrogens
Abstract : Exposure to pharmacological dosages of estrogens, including 17 beta- estradiol and DES, selectively affects immune… 
1980
1980
Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
The interference of two weak estrogens (P-1496 and P-1560) on the binding of estradiol with uterine estrogen receptors is… 
1977
1977
Glucose tolerance in postmenopausal women receiving a new, non-steroidal estrogen-like compound, P-1496.
1977
1977
[Relationship between uterotropic effects and binding to estrogen receptors of 17B-estradiol and P-1496].
1976
1976
Treatment of the menopausal syndrome with a new non-steroid estrogen-like drug: P-1496.